Entresto is a combination medication containing Sacubitril, a neprilysin inhibitor, and Valsartan, an angiotensin II receptor blocker (ARB). This combination works synergistically to relax blood vessels, reduce sodium retention, and decrease strain on the heart, thereby improving heart function in patients with heart failure.